A detailed history of Westhampton Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Westhampton Capital, LLC holds 5,510 shares of MRK stock, worth $568,191. This represents 0.32% of its overall portfolio holdings.

Number of Shares
5,510
Previous 5,510 -0.0%
Holding current value
$568,191
Previous $682,000 8.36%
% of portfolio
0.32%
Previous 0.37%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$123.8 - $132.96 $12,627 - $13,561
-102 Reduced 1.82%
5,510 $682,000
Q1 2024

Apr 18, 2024

BUY
$113.24 - $131.95 $113 - $131
1 Added 0.02%
5,612 $740,000
Q4 2023

Jan 19, 2024

SELL
$100.18 - $109.02 $44,580 - $48,513
-445 Reduced 7.35%
5,611 $611,000
Q3 2023

Oct 25, 2023

BUY
$102.95 - $114.33 $623,465 - $692,382
6,056 New
6,056 $623,000
Q1 2023

Apr 14, 2023

BUY
$102.94 - $114.86 $5,147 - $5,743
50 Added 0.92%
5,505 $585,000
Q4 2022

Jan 25, 2023

BUY
$87.44 - $112.11 $56,836 - $72,871
650 Added 13.53%
5,455 $0
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $150,528 - $165,543
-2,100 Reduced 30.41%
4,805 $361,000
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $7,031 - $7,777
100 Added 1.47%
6,905 $537,000
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $3,443 - $4,055
50 Added 0.74%
6,805 $525,000
Q4 2020

Feb 03, 2021

SELL
$71.77 - $79.65 $40,908 - $45,400
-570 Reduced 7.78%
6,755 $553,000
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $2,561 - $2,903
35 Added 0.48%
7,325 $608,000
Q2 2020

Jul 17, 2020

SELL
$70.42 - $80.13 $19,365 - $22,035
-275 Reduced 3.64%
7,290 $564,000
Q1 2020

Apr 30, 2020

BUY
$63.36 - $87.82 $69,696 - $96,601
1,100 Added 17.01%
7,565 $582,000
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $451,515 - $527,479
6,465 New
6,465 $542,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Westhampton Capital, LLC Portfolio

Follow Westhampton Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westhampton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westhampton Capital, LLC with notifications on news.